Topical tacrolimus (FK506) for the treatment of feline idiopathic facial dermatitis.
A 3-year-old, neutered male Persian cat with chronic ulcerative facial dermatitis was diagnosed with feline idiopathic facial dermatitis based on signalment, clinical history and diagnostic test results, including dermatohistopathological evaluation. Initial treatment started with 4 weeks of oral antifungal/antibiotic medication for severe secondary infectious dermatitis of Malassezia and bacteria. As the lesions gradually improved, the oral medication was withdrawn, leaving only 0.1% topical FK506 (tacrolimus) ointment for the remaining lesions. Topical treatment was administered just in case any new lesions developed. The patient has been managed effectively with topical tacrolimus and no side-effects were observed during treatment. Feline idiopathic facial dermatitis is known as a difficult dermatosis to manage successfully, but our experience suggests that it may respond to topical tacrolimus.
Departments of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, South Korea.
T-H
TH
Chung
M-H
MH
Ryu
D-Y
DY
Kim
H-Y
HY
Yoon
C-Y
CY
Hwang
D000287:Administration, Topical; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D002415:Cats; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008290:Malassezia / Q000254:growth & development*; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use*
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus